QuantumScape Corp
For the period ended Mar 31, 2026. Filed Apr 24, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 24, 2026
QS$4.45-2.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (Unaudited)
(In Thousands)
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Operating activities | ||
| Net loss | $(100,799) | $(114,423) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 14,760 | 18,335 |
| Amortization of right-of-use assets and non-cash lease expense | 2,554 | 2,046 |
| Accretion of discounts on marketable securities | (4,498) | (5,048) |
| Stock-based compensation expense | 30,509 | 40,639 |
| Other | 454 | 40 |
| Changes in operating assets and liabilities: | ||
| Prepaid expenses and other current assets and other assets | (412) | 472 |
| Accounts payable, accrued liabilities and accrued compensation and benefits | (880) | (1,532) |
| Operating lease liability and other liabilities | (1,199) | (1,278) |
| Net cash used in operating activities | (59,511) | (60,749) |
| Investing activities | ||
| Purchases of property and equipment | (9,980) | (5,835) |
| Proceeds from maturities of marketable securities | 231,953 | 281,220 |
| Purchases of marketable securities | (247,836) | (213,352) |
| Other | 174 | — |
| Net cash (used in) provided by investing activities | (25,689) | 62,033 |
| Financing activities | ||
| Proceeds from exercise of stock options | 614 | 11,182 |
| Proceeds from issuance of common stock, net of issuance costs paid | — | 1,007 |
| Principal payment for finance lease | (870) | (784) |
| Net cash (used in) provided by financing activities | (256) | 11,405 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (85,456) | 12,689 |
| Cash, cash equivalents and restricted cash at beginning of period | 244,179 | 158,914 |
| Cash, cash equivalents and restricted cash at end of period | $158,723 | $171,603 |
| Supplemental disclosure: | ||
| Cash paid for interest | $478 | $528 |
| Purchases of property and equipment, not yet paid | $3,905 | $4,624 |
| Common stock issuance costs, not yet paid | $— | $110 |
The following table presents the Company’s cash, cash equivalents and restricted cash by category in the Company’s Condensed Consolidated Balance Sheets (Unaudited) (amounts in thousands):
| As of March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash and cash equivalents | $145,068 | $153,555 |
| Other assets | 13,655 | 18,048 |
| Total cash, cash equivalents and restricted cash | $158,723 | $171,603 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.